Impact of hepatorenal function and clinical outcomes in patients with liver cirrhosis combined with systemic inflammatory response syndrome

Clinical Focus ›› 2012, Vol. 27 ›› Issue (24): 2117-2120.

Previous Articles Next Articles

Impact of hepatorenal function and clinical outcomes in patients with liver cirrhosis combined with systemic inflammatory response syndrome

ZHANG Jing;SANG Hai-tong

Online:2012-12-20 Published:2012-12-20

Abstract

CLC Number:

R575.2

ZHANG Jing;SANG Hai-tong. Impact of hepatorenal function and clinical outcomes in patients with liver cirrhosis combined with systemic inflammatory response syndrome[J]. Clinical Focus, 2012, 27(24): 2117-2120.

Add to citation manager EndNote|Ris|BibTeX

URL: http://www.lchc.cn/EN/

http://www.lchc.cn/EN/Y2012/V27/I24/2117

[1]	Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun. Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis [J]. Clinical Focus, 2025, 40(4): 293-303.
[2]	Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin. Value of T₂WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients [J]. Clinical Focus, 2025, 40(3): 251-256.
[3]	Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi. Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis [J]. Clinical Focus, 2025, 40(2): 143-146.
[4]	Zhang Shasha, Zhao Yingchun, Zhou Hongxia. Effect of low-level viremia on the incidence of hepatocellular carcinomas in patients with hepatitis B cirrhosis treated with entecavir [J]. Clinical Focus, 2024, 39(11): 980-983.
[5]	. [J]. Clinical Focus, 2024, 39(7): 658-663.
[6]	Wang Qingli;Yang Lin;Liu Qi. Clinical observation on effect of coffeic acid on leukocyte anal platelet count in patients with cirrhosis [J]. Clinical Focus, 2015, 30(9): 1027-1.0281e+007.
[7]	Ge Xiuzhen;Wang Yuming;Zheng Zhongqing;Wang Tao;Wang Bangmao. Risk factors in poor prognosis after endoscopic variceal ligation and endoscopic injection sclerotherapy of esophageal varices caused by liver cirrhosis [J]. Clinical Focus, 2015, 30(3): 250-252256.
[8]	. [J]. CLINICAL FOCUS, 2014, 29(3): 350-350.
[9]	HE Qing-hong;HUANG Wei. Application of color Doppler sonography predicting cirrhotic portal hypertension with esophageal varices rupture hemorrhage [J]. CLINICAL FOCUS, 2014, 29(3): 295-297.
[10]	XIAO Qi;FENG Ai-dong;LIU Zhi-quan;FENG Jun-hua;DU Rui-qing;YE Li-hong;MEI Zhi-qin;DAI Er-hei. Value and impact factors of transient edoi:graphy in diagnosis of hepatitis B cirrhosis [J]. CLINICAL FOCUS, 2013, 28(8): 855-857860.
[11]	ZHAO Tian-yu;MA Chun-ye;LI Chun-yan. Analysis of cirrhosis patients with hepatic encephalopathy prognostic factors [J]. Clinical Focus, 2013, 28(4): 406-408.
[12]	WANG Jun-ming;CHEN Chun-yan;LI Yan;HANG Jing-xian;ZHANG Zhi-gang. Relationship between fatty liver and carotid atherosclerosis in different age populations [J]. Clinical Focus, 2013, 28(1): 11-13.
[13]	. [J]. Clinical Focus, 2012, 27(22): 1979-1980.
[14]	LI Chun-sheng;GUO Jin-bo;XU Yun-feng;TIAN Hui;WEI Juan;ZHANG Guo-zun;LIU Lei;FANG Shu-ming;ZHANG Xiao-lan. Effects of salvia miltiorrhiza monomer IH764-3 on collagen metabolism and mechanism in hepatic stellate cells [J]. Clinical Focus, 2012, 27(17): 1502-1505.
[15]	. [J]. Clinical Focus, 2012, 27(6): 550-552.

Impact of hepatorenal function and clinical outcomes in patients with liver cirrhosis combined with systemic inflammatory response syndrome

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments